Skip to content

Released May 8, 2017, before the open

10-Q filed May 8, 2017, 38 days after period end · 0001144204-17-024980

Q1 2017 · 10-Q
Revenue$0.00no prior Q1 2016 on fileno prior Q4 2016 on file
Net Income-$4.86MN/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$0.26N/M vs Q1 2016N/M vs Q4 2016
Operating Income-$4,908,915N/M
Operating Cash Flow-$3,138,751N/M
Free Cash Flowderived-$3,138,751N/M

What the release said

The release

Same quarter

MetricQ1 2017Q1 2016Q1 2015Q1 2014
Revenue$0.00———
Net Income-$4.86M-$7.01M-$2.96M-$5.27M
EPS Diluted-$0.26-$0.38-$0.23-$0.41

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR